:: Consuming more plant omega-3 alpha-linolenic acid (ALA) like walnuts
:: and flaxseeds oil improves bone health according to a new controlled
[quoted text clipped - 10 lines]
: and ~ 20 grams flaxseed oil daily. Walnuts are an exceptionally high
: source of myricetin and a good source of gamma-tocopherol.
Actually there is some evidence for the benefit of myricetin and vitamin E.
Myricetin increases bone formation and vitamin E may suppress bone
resorption.
(1) Biochem Pharmacol. 2007 Feb 15;73(4):504-14. Epub 2006 Oct 26.
Myricetin induces human osteoblast differentiation through bone
morphogenetic protein-2/p38 mitogen-activated protein kinase pathway.
Hsu YL, Chang JK, Tsai CH, Chien TT, Kuo PL.
Department of Pharmacy, Chia-Nan University of Pharmacy and Science, Tainan,
Taiwan.
Myricetin (3,3',4',5,5',7-hexahydroxyflavone), a flavonoid compound, is
present in vegetables and fruits. By means of alkaline phosphatase (ALP)
activity, osteocalcin, and type I collagen enzyme-linked immunosorbent assay
(ELISA), we have shown that myricetin exhibits a significant induction of
differentiation in MG-63 and hFOB human osteoblasts. Alkaline phosphatase
and osteocalcin are phenotypic markers for early-stage differentiated
osteoblasts and terminally differentiated osteoblasts, respectively. Our
results indicate that myricetin stimulates osteoblast differentiation at
various stages, from maturation to terminally differentiated osteoblasts.
Induction of differentiation by myricetin is associated with increased bone
morphogenetic protein-2 (BMP-2) production. The BMP-2 antagonist noggin
blocked myricetin-mediated ALP activity and osteocalcin secretion
enhancement, indicating that BMP-2 production is required in
myricetin-mediated osteoblast maturation and differentiation. Induction of
differentiation by myricetin is associated with increased activation of
SMAD1/5/8 and p38 mitogen-activated protein kinases. Cotreatment of p38
inhibitor SB203580 inhibited myricetin-mediated ALP upregulation and
osteocalcin production. In conclusion, myricetin increased BMP-2 synthesis,
and subsequently activated SMAD1/5/8 and p38 MAPK, and this effect may
contribute to its action on the induction of osteoblast maturation and
differentiation, followed by an increase of bone mass. PMID: 17113042
(2) J Womens Health (Larchmt). 2006 Apr;15(3):295-300.
Antioxidant vitamin supplements and markers of bone turnover in a community
sample of nonsmoking women.
Pasco JA, Henry MJ, Wilkinson LK, Nicholson GC, Schneider HG, Kotowicz MA.
The University of Melbourne, Department of Clinical and Biomedical Sciences,
Barwon Health, Geelong, Victoria, Australia.
BACKGROUND: Whereas several epidemiological studies suggest that low dietary
intake of vitamins C and E is linked to increased hip fracture in smokers
and antioxidants (dietary and endogenous) are reduced in elderly
osteoporotic women, none has demonstrated an effect of supplemental
antioxidants on bone turnover. METHODS: In an observational study of 533
randomly selected women, we investigated the associations among the use of
antioxidant supplements, vitamins C and E, serum levels of biochemical
markers of bone turnover (C-telopeptide [CTx] and bone-specific alkaline
phosphatase [BSAP]), and whole body bone mineral density (BMD). RESULTS:
Twenty-two women were identified as current users of supplemental vitamin C
or E. Duration of antioxidant supplement use was negatively associated with
age-adjusted and weight-adjusted serum CTx, such that mean CTx levels
(natural log transformed) were 0.022 units lower for each year of exposure.
No significant differences were detected for adjusted serum BSAP or whole
body BMD. CONCLUSIONS: Our results suggest that antioxidant vitamin E or C
supplements may suppress bone resorption in nonsmoking postmenopausal women.
Coupling of bone formation and resorption may explain the absence of an
effect on bone formation markers, given evidence of enhanced effects of
antioxidants on osteoblast differentiation; this warrants further
investigation. This work adds to the growing body of evidence that
antioxidants may play a role in preventing osteoporosis. PMID: 16620188

Signature
Juhana